http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111643430-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-81
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-678
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789
filingDate 2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111643430-B
titleOfInvention Eye essence for treating dark eye circles by cooperation with laser and preparation method thereof
abstract The invention belongs to the technical field of cosmetics, and particularly relates to eye essence for synergistically treating dark eye circles by laser and reducing complications of laser treatment and a preparation method thereof, wherein the eye essence comprises the following components in percentage by mass: 1-10% of efficacy composition, 1-3% of dioctyl carbonate, 1-3% of isononyl isononanoate, 0.1-0.3% of vitamin E, 1-3% of glycerol, 0.1-0.5% of hyaluronic acid, 1-3% of cetearyl glucoside, 201-3% of ceteth-201, 0.1-0.3% of ammonium acryloyl dimethyl taurate/VP copolymer, 0.01-0.03% of EDTA-2NA, 0.1-0.2% of phenoxyethanol and the balance of deionized water; the efficacy composition comprises 1-10% of gamma-aminobutyric acid, 40-60% of saxifrage extract and 20-50% of arachnoid blue extract. The eye essence provided by the invention can effectively remove the pigment and mixed dark eye circles by combining laser treatment, and simultaneously reduces the occurrence of complications such as eye erythema, stabbing pain, swelling, pigmentation and the like, and makes a remarkable progress compared with the prior art.
priorityDate 2020-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456420185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410564071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93286832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410570770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260480
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5459840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415806093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20669575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24843097
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412833275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9904000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587762

Total number of triples: 66.